Diagnosis Rates Alarmingly Low
The International OCD Care and Development Foundation released its first white paper in December 2025. Titled America’s OCD Care Crisis, the report analyzes healthcare data from over 10 million Americans. It reveals that only 0.69% of this group were diagnosed with or highly likely to have OCD. This finding exposes a critical gap in diagnosis and treatment access.
Wellness insights
Social support networks of older adults before, during and after the COVID-19 pandemic
College Mental Health Crisis Shows Signs of Easing
Why Depression Subtypes Matter: 25 Years of Clinical Lessons
Choosing Adjunctive Therapy for Major Depressive Disorder: A Focus on Non-NegotiablesThe data shows that most people with OCD symptoms never receive a formal diagnosis. Without diagnosis, patients cannot access specialized therapy or medication. This creates a vicious cycle where lack of care delays clinical research. Researchers struggle to recruit participants when the patient pool is so small. The IOCDF argues that improving diagnosis rates is the first step to unlocking research progress.
How Does the Care Gap Affect Research?
When few patients are identified, clinical trials face recruitment challenges. Studies require diverse, well-characterized cohorts to produce reliable results. The white paper highlights that the current care model fails to connect patients with evidence-based treatments like CBT and SSRIs. This bottleneck means new therapies take longer to reach the people who need them.
Frequently Asked Questions
What is the IOCDF white paper? It is a data-driven report analyzing OCD diagnosis and treatment gaps across the U. S. population. It uses healthcare records from over 10 million Americans.
Why is the 0.69% figure significant? It shows that fewer than 1 in 144 Americans are formally diagnosed or highly likely to have OCD. This low rate indicates widespread underdiagnosis, which directly limits the patient pool available for clinical research.
